Leucovorin CalciumThird Party Manufacturing in India

Leucovorin Calcium is a reduced form of folic acid that serves as an essential coenzyme in nucleic acid synthesis. As the 5-formyl derivative of tetrahydrofolic acid, leucovorin does not require reduction by dihydrofolate reductase (DHFR) to participate in one-carbon transfer reactions, which makes it uniquely valuable as a rescue agent. The pharmacologically active isomer, levoleucovorin, and its metabolites serve as essential cofactors in the biosynthesis of purines and pyrimidines. In the context of methotrexate therapy, leucovorin bypasses the DHFR blockade caused by methotrexate, providing an exogenous source of reduced folates that rescues normal cells from methotrexate-induced toxicity while allowing the antineoplastic effect to continue in tumor cells. In combination with fluorouracil, leucovorin enhances anticancer activity by stabilizing the binding of the fluorouracil metabolite fluorodeoxyuridylic acid to thymidylate synthase, thereby increasing inhibition of DNA synthesis. This dual role as both a rescue agent and a biomodulator makes leucovorin indispensable in modern oncology protocols, particularly in high-dose methotrexate regimens and fluorouracil-based colorectal cancer therapy.

Therapeutic Uses

Leucovorin Calcium is prescribed for:

• Leucovorin Rescue After High-Dose Methotrexate: To reduce the toxicity of methotrexate in patients with impaired methotrexate elimination, allowing for safe administration of high-dose methotrexate therapy in osteosarcoma and other malignancies.
• Overdose of Folic Acid Antagonists: As an antidote for overdose of methotrexate and other DHFR inhibitors such as trimethoprim and pyrimethamine.
• Colorectal Cancer Therapy: In combination with 5-fluorouracil (with or without irinotecan or oxaliplatin) as first-line therapy for advanced colorectal cancer, where it potentiates the antitumor activity of fluorouracil.
• Cerebral Folate Transport Deficiency: For adult and pediatric patients with a confirmed variant in the folate receptor 1 gene (FOLR1-CFTD).

Why Manufacturers Choose Leucovorin Calcium

Leucovorin Calcium is a high-volume oncology support medication used extensively in hospital cancer care. Its role as an essential component of the FOLFIRI and FOLFOX regimens for colorectal cancer ensures consistent and growing demand. The drug is listed on the WHO Essential Medicines List. Injectable formulations are preferred in hospital settings, making liquid injection a stable revenue product for manufacturers serving the oncology market.

This makes Leucovorin Calcium a high-demand molecule for third party manufacturing in India, with steady requirements from cancer hospitals and export channels supplying global healthcare markets.